Posted by Michael Wonder on 19 Mar 2021
Too fast or too slow: is the FDA moving at the right speed?
19 March 2021 - Regardless of President Joe Biden’s choice for the next commissioner of the FDA, the Senate Health, Education, Labor and Pensions Committee will likely pose one question above all others to the nominee: Is the FDA approving drugs too quickly or too slowly?
As someone who has seen the FDA from the inside as an associate commissioner, I can attest to the tremendous pride that the agency takes in the thoughtful, savvy, and swift introduction of new medicines through the review process.
